Target intelligence / Profile preview

Ribosomal protein S2 pseudogene 41 (RPS2P41)

Target
RPS2P41
Molecular classification
Other (annotated as a pseudogene, not an active protein, enzyme, receptor, or therapeutic target class)
01

Overview

Ribosomal protein S2 pseudogene 41 (RPS2P41) is a processed pseudogene of the ribosomal protein S2 gene (RPS2). Pseudogenes are genomic DNA sequences similar to known genes but non-functional; they are usually derived from reverse transcription and integration into the genome or from duplications followed by disabling mutations. RPS2P41 does not encode a functional ribosomal protein and has no reported biological or clinical function. The functional parent gene, RPS2, encodes a component of the cytoplasmic 40S ribosomal subunit, but RPS2P41 is one of several dispersed, inactive copies that arose throughout evolution and are typically catalogued for genomic annotation or evolutionary studies[5]. There is no evidence for RPS2P41 being a protein-coding gene, drug target, or disease gene[5]. Clarifications: - The requested target ("Ribosomal protein S2 pseudogene 41", RPS2P41) is a pseudogene, not an active ribosomal protein, nor a known receptor, enzyme, or therapeutic target[5]. - The gene RPS2 is active and protein-coding, but RPS2P41 is only a non-functional genetic element[5][3][4]. - Pseudogenes like RPS2P41 typically do not participate in biological functions or pathways, nor do they have interactions with drugs[5]. While rare non-coding RNAs or regulatory effects can be described for other pseudogenes, such roles are not described or recognized for RPS2P41.

02

Mechanism of action

None

Beyond the preview

Go deeper on Ribosomal protein S2 pseudogene 41 (RPS2P41).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein S2 pseudogene 41 (RPS2P41).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call